120 related articles for article (PubMed ID: 15167202)
1. The Swedish National Programme for Quality Control of Secondary Prevention of Coronary Artery Disease--results after one year.
Stagmo M; Israelsson B; Brandström H; Hedbäck B; Lingfors H; Nilsson P; Erhardt L
Eur J Cardiovasc Prev Rehabil; 2004 Feb; 11(1):18-24. PubMed ID: 15167202
[TBL] [Abstract][Full Text] [Related]
2. Cardiology management improves secondary prevention measures among patients with coronary artery disease.
Ho PM; Masoudi FA; Peterson ED; Grunwald GK; Sales AE; Hammermeister KE; Rumsfeld JS
J Am Coll Cardiol; 2004 May; 43(9):1517-23. PubMed ID: 15120805
[TBL] [Abstract][Full Text] [Related]
3. Secondary prevention of coronary artery disease in contemporary clinical practice.
Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
[TBL] [Abstract][Full Text] [Related]
4. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Cardiovasc Diabetol; 2015 Oct; 14():133. PubMed ID: 26427624
[TBL] [Abstract][Full Text] [Related]
5. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP).
Fonarow GC; Gawlinski A; Moughrabi S; Tillisch JH
Am J Cardiol; 2001 Apr; 87(7):819-22. PubMed ID: 11274933
[TBL] [Abstract][Full Text] [Related]
6. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
[TBL] [Abstract][Full Text] [Related]
7. Secondary prevention in patients after hospitalisation due to coronary artery disease: what has changed since 2006?
Jankowski P; Czarnecka D; Lysek R; Skrzek A; Smaś-Suska M; Mazurek A; Brzozowska-Kiszka M; Wolfshaut-Wolak R; Surowiec S; Bogacki P; Bryniarska-Mirek E; Bryniarski L; Grodecki J; Nessler J; Olszowska M; Podolec P; Kawecka-Jaszcz K; Pająk A
Kardiol Pol; 2014; 72(4):355-62. PubMed ID: 24408064
[TBL] [Abstract][Full Text] [Related]
8. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
[TBL] [Abstract][Full Text] [Related]
9. Glycaemic control and cardiovascular risk factor management in patients with diabetes with and without coronary artery disease: insights from the diabetes mellitus status in Canada survey.
Grenier J; Leiter LA; Langer A; Goldin L; Teoh H; Connelly KA; Cheng AYY; Tan MK; Fitchett D; McGuire DK; Goodman SG; Yan AT
Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):277-284. PubMed ID: 29474711
[TBL] [Abstract][Full Text] [Related]
10. Cost of lipid lowering in patients with coronary artery disease by case method learning.
Kiessling A; Zethraeus N; Henriksson P
Int J Technol Assess Health Care; 2005; 21(2):180-6. PubMed ID: 15921057
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol end points predict outcome in patients with coronary disease: quality improvement metrics from the enhancing secondary prevention in coronary artery disease (ESP-CAD) trial.
McAlister FA; Majumdar SR; Lin M; Bakal J; Fradette M; Anderson T
Can J Cardiol; 2014 Dec; 30(12):1627-32. PubMed ID: 25307535
[TBL] [Abstract][Full Text] [Related]
12. Management and clinical outcome of stable coronary artery disease in Austria : Results from 5 years of the CLARIFY registry.
Lang IM; Badr-Eslam R; Greenlaw N; Young R; Steg PG
Wien Klin Wochenschr; 2017 Dec; 129(23-24):879-892. PubMed ID: 28913755
[TBL] [Abstract][Full Text] [Related]
13. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267
[TBL] [Abstract][Full Text] [Related]
14. Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations : A joint scientific statement from the Austrian Society of Cardiology and the Austrian Society of Hypertension.
Weber T; Lang I; Zweiker R; Horn S; Wenzel RR; Watschinger B; Slany J; Eber B; Roithinger FX; Metzler B
Wien Klin Wochenschr; 2016 Jul; 128(13-14):467-79. PubMed ID: 27278135
[TBL] [Abstract][Full Text] [Related]
15. Serum cholesterol, lifestyle, working capacity and quality of life in patients with coronary artery disease. Experiences from a hospital-based secondary prevention programme.
Carlsson R
Scand Cardiovasc J Suppl; 1998; 50():1-20. PubMed ID: 9802147
[TBL] [Abstract][Full Text] [Related]
16. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
EUROASPIRE II Study Group
Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
[TBL] [Abstract][Full Text] [Related]
17. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
[TBL] [Abstract][Full Text] [Related]
18. Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.
Kumbhani DJ; Fonarow GC; Cannon CP; Hernandez AF; Peterson ED; Peacock WF; Laskey WK; Deedwania P; Grau-Sepulveda M; Schwamm LH; Bhatt DL;
Am J Med; 2015 Apr; 128(4):426.e1-9. PubMed ID: 25433302
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk factor control is insufficient in young patients with coronary artery disease.
Christiansen MK; Jensen JM; Brøndberg AK; Bøtker HE; Jensen HK
Vasc Health Risk Manag; 2016; 12():219-27. PubMed ID: 27307744
[TBL] [Abstract][Full Text] [Related]
20. Nurses' observational study on the practice of secondary prevention in a cardiovascular department.
Steffenino G; Galliasso M; Gastaldi C; Ricca N; Mangiacotti B
Ital Heart J; 2003 Jul; 4(7):473-8. PubMed ID: 14558299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
